We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

HORIBA Medical

HORIBA ABX designs, develops and distributes worldwide, in vitro diagnostic systems for biological analysis in medica... read more Featured Products: More products

Download Mobile App





Horiba Medical Exhibits New Generation of Automated Hematology Analyzers at MEDLAB Middle East 2021

By LabMedica International staff writers
Posted on 23 Jun 2021
Horiba Medical (Kyoto, Japan) presented its high-end hematology solutions alongside different configurations of laboratory organization as well as its comprehensive range of hemostasis and clinical chemistry instruments at MEDLAB Middle East 2021.

On display at the event were the Yumizen H2500, Yumizen SPS and Yumizen P8000 - the new generation of Horiba automated hematology analyzers that answers customers’ expectations of solid and reliable diagnostic technology as well as rapid and consistent results. More...
Some of their features include a real throughput of 120 samples per hour for CBC-DIFF, NRBC included, sampling volume of 110μl (CBC, DIFF, BF) and 75μL (Slide), only six reagents, automatic 360° rotative sample mixing for perfect homogeneity, two PLT technologies - Impedance & Optical extinction – and three WBC counts in CBC and differential modes. All the instruments are compatible with the HELO Solution (HORIBA Evolutive Laboratory Organization).

Horiba also showcased its Yumizen H500 and H550 analyzers that have been designed to deliver a rapid and comprehensive hematology report with a throughput of 60 tests/hour, 40 tubes autonomy with continuous loading, urgent manual mode; and for running samples through multi analysis modes and sampling. Based on color codes, minimum operation and quality flagging messages, the ergonomics of the new Yumizen H500 and H550 are perfectly dedicated to users of small size laboratories such as emergency rooms or physician office labs. With its menu of extensive parameters and enhanced clinical performances the new Yumizen H500 and H550 analyzers are capable of meeting the demands of a variety of clinical lab environments and clinical settings: routine hematology, satellites labs, oncology care, blood banks.

In addition, Horiba highlighted the Microsemi LC-667G hematology analyzer featuring the exclusive concept of simultaneous blood analysis + CRP measurement, along with data management. It is the first hematology analyzer to offer malaria screening flag combined with CBC count. The Malaria screening flag with high sensitivity alerts the physician about suspicion of malaria infection and is available in CBC or CBC+CRP routine use without any specific reagent or dedicated mode. The added value is part of a complete solution of using the MicrosEmi CRP as an infectious differentiator.

Related Links:
Horiba Medical


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Laboratory Software
ArtelWare
Automated MALDI-TOF MS System
EXS 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Monarch Mag Cell-free DNA (cfDNA) Extraction Kit provides isolation of low-abundance cfDNA from a range of biofluids (Photo courtesy of New England Biolabs)

New Extraction Kit Enables Consistent, Scalable cfDNA Isolation from Multiple Biofluids

Circulating cell-free DNA (cfDNA) found in plasma, serum, urine, and cerebrospinal fluid is typically present at low concentrations and is often highly fragmented, making efficient recovery challenging... Read more

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Pathology

view channel
Image: The innovative classifier can guide treatment for PDAC and other immunotherapy-resistant cancers (Photo courtesy of Adobe Stock))

Single Sample Classifier Predicts Cancer-Associated Fibroblast Subtypes in Patient Samples

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers, in part because of its dense tumor microenvironment that influences how tumors grow and respond to treatment.... Read more

Industry

view channel
Image: QuidelOrtho has entered into a strategic supply agreement with Lifotronic to expand its global immunoassay portfolio (Photo courtesy of QuidelOrtho)

QuidelOrtho Collaborates with Lifotronic to Expand Global Immunoassay Portfolio

QuidelOrtho (San Diego, CA, USA) has entered a long-term strategic supply agreement with Lifotronic Technology (Shenzhen, China) to expand its global immunoassay portfolio and accelerate customer access... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.